Top Tweets for #TrueSignature
Attending #HUPO2024 in Dresden? Join us as we showcase our cutting-edge #proteomics services platforms #TrueDiscovery®, #TrueSignature®, and #TrueTarget® across various oral & poster sessions. Don't miss @ArthurViode's presentation on Oct 23!
Learn more: https://t.co/es3jLUnoQq
Our collaborator Grey Wolf Therapeutics showcased a poster at #ASCO2024 on immunopeptidome modulation with the ERAP1 inhibitor GRWD5769. #TrueDiscovery® and #TrueSignature® enabled comprehensive analysis - crucial for phase II dosing. Download now! https://t.co/Ij1AW8g6D6
Don't miss our #ASMS2024 breakfast seminar on June 3rd! Learn how @KymeraTx use our #TrueSignature® panels, how @Biogen explores mass spec assays for clinical #biomarker profiling and our new #TrueDiscovery® #Plasma #Proteomics service.
Secure your spot: https://t.co/oCkGp0r0Ee
"It's the last exhibition day at #AACR2024! Don't miss our poster on MS-based #pharmacokinetic analysis of 'Omomyc' in solid cancers in collaboration with @Peptomyc. Swing by booth #1745 for a chat and pick up your goodies. #TrueSignature®
more: https://t.co/4AdbRF94Ty
👏 Congrats to @LauraSoucek and the team at @peptomyc for their remarkable phase 1 clinical study featured in @NatureMedicine! We take pride in contributing to this research through our customizable #TrueSignature® targeted proteomics panels.
More: https://t.co/kwMiFAYI9l
Unleash precision in #Pharmacodynamic studies with #TrueSignature® custom hyperplex panels for precise and absolute quantification of up to 800 protein biomarkers: a game-changer for efficacy and safety assessments.
https://t.co/AcsvvMq0uA
#MassSpectrometry #ClinicalResearch
🚀 Discover our new #TrueSignature® custom hyperplex panels, powered by parallel reaction monitoring (#PRM) and #SureQuant, to elevate your clinical biomarker and pharmacodynamic analysis. Precisely quantify up to 800 peptide analytes.🧬https://t.co/FAoZd9gJOt
Congrats to @KymeraTx on their Nature Medicine publication on the Ph1 trial of their IRAK4 targeted protein degrader, KT-474. The #TrueSignature custom #TPD panel that we developed proved highly effective for monitoring PD markers. https://t.co/NZzKNzWVlm
In this #HUPO2023 poster, @GenMab assessed the performance of our #TrueDiscovery and #TrueSignature mass spectrometry #proteomics platforms compared to flow cytometry for the discovery and validation of #ImmunoOncology targets in human immune cells. https://t.co/3ZcORuDWQ8
We are excited to present 10 posters at #HUPO2023! 🎉 4 highlight research performed using our #TrueDiscovery and #TrueSignature platforms. The posters cover a range of topics, including immune-oncology and plasma studies. More: https://t.co/iMfM7jUhth
Using peptides as surrogates, #MassSpectrometry-based approaches reduce barriers in preclinical #drugdevelopment. At #AACR23 we showcased our #TrueSignature targeted panels for quantifying pharmacodynamic markers. https://t.co/Io8kIZXBVm
Blocking MYC is the holy grail for cancer treatment, and Omomyc is the first peptide targeting MYC. To overcome the drug development challenges, the researchers have relied on our next-generation #proteomics platform #TrueSignature. More: https://t.co/4GIDdnNbpW
During the inauguration event for our Cambridge (MA) offices on Oct 12, @KymeraTx’ Alice McDonald, and Eric Kuhn will share their experience with Biognosys’ #TrueSignature custom biomarker panels. More info & registration: https://t.co/9LNYedHdSw
Read the full press release about Biognosys’ and @KymeraTx’s partnership on precision #proteomics #biomarkers on our website: https://t.co/Xse5T4dhzb
@kristina_beeler #TrueSignature #ClinicalTrials #DrugDiscovery
#DrugDevelopment
Our #TrueSignature proteomics panels serve as pharmacodynamic readout for protein degradation in @KymeraTx’s discovery and clinical trial programs @NelloMainolfi comments on the partnership in our Press Release: https://t.co/hm2a59bPPc
We’re thrilled to announce our partnership with @KymeraTx in precision proteomics #biomarkers. Biognosys’ #TrueSignature #proteomics panels serve as pharmacodynamic readout for protein degradation in Kymera’s discovery and clinical trial programs.
PR: https://t.co/A7qzlPSgmy
With the launch of our #TrueDiscovery, #TrueTarget, and #TrueSignature proteomics platforms, we now provide transformative insights from discovery to clinic. Explore how our platforms can revolutionize your research journey at https://t.co/5HCEnIQHf8
Last Seen Hashtags on Sotwe
anxiouspanda()************************ filter:videos
incesto tio y sobrina
Seen from Ecuador
anxiouspanda
Seen from Guatemala
公交车
Seen from United States
zelal
Seen from Turkey
minichat
Seen from United States
舞团
countdown
Seen from Poland
aov gay
Seen from Vietnam
incesto hermano()*+filter:native_video
Seen from Mexico
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
241.7M followers
Barack Obama
@barackobama
118.9M followers
Cristiano Ronaldo
@cristiano
114.6M followers
Donald J. Trump
@realdonaldtrump
111.9M followers
Narendra Modi
@narendramodi
107.2M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.4M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90.1M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.5M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.5M followers
Bill Gates
@billgates
65.2M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.3M followers
CNN
@cnn
61.8M followers
X
@x
60.7M followers